These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 28666902)

  • 1. Intensity modulated radiation therapy with pulsed reduced dose rate as a reirradiation strategy for recurrent central nervous system tumors: An institutional series and literature review.
    Murphy ES; Rogacki K; Godley A; Qi P; Reddy CA; Ahluwalia MS; Peereboom DM; Stevens GH; Yu JS; Kotecha R; Suh JH; Chao ST
    Pract Radiat Oncol; 2017; 7(6):e391-e399. PubMed ID: 28666902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-irradiation of recurrent head and neck cancers using pulsed reduced dose rate radiotherapy: An institutional series.
    Megahed R; Prabhu AV; Mack DP; Gholami S; Samanta S; Patel M; Lewis GD
    Oral Oncol; 2024 May; 152():106778. PubMed ID: 38555751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wide-field pulsed reduced dose rate radiotherapy (PRDR) for recurrent ependymoma in pediatric and young adult patients.
    Mohindra P; Robins HI; Tomé WA; Hayes L; Howard SP
    Anticancer Res; 2013 Jun; 33(6):2611-8. PubMed ID: 23749916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.
    Freese C; Takiar V; Fouladi M; DeWire M; Breneman J; Pater L
    Pract Radiat Oncol; 2017; 7(2):86-92. PubMed ID: 28274399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encouraging early clinical outcomes with helical tomotherapy-based image-guided intensity-modulated radiation therapy for residual, recurrent, and/or progressive benign/low-grade intracranial tumors: a comprehensive evaluation.
    Gupta T; Wadasadawala T; Master Z; Phurailatpam R; Pai-Shetty R; Jalali R
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):756-64. PubMed ID: 21345610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulsed Reduced Dose Rate for Reirradiation of Recurrent Breast Cancer.
    Burr AR; Robins HI; Bayliss RA; Howard SP
    Pract Radiat Oncol; 2020; 10(2):e61-e70. PubMed ID: 31526900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reirradiation for recurrent primary central nervous system tumors: Eight-year audit from a tertiary cancer care center in South India.
    Menon D; Chelakkot PG
    Indian J Cancer; 2017; 54(2):409-414. PubMed ID: 29469068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis.
    Caudell JJ; Ward MC; Riaz N; Zakem SJ; Awan MJ; Dunlap NE; Isrow D; Hassanzadeh C; Vargo JA; Heron DE; Marcrom S; Boggs DH; Reddy CA; Dault J; Bonner JA; Higgins KA; Beitler JJ; Koyfman SA; Machtay M; Yao M; Trotti AM; Siddiqui F; Lee NY;
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):606-617. PubMed ID: 29413274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme.
    Fuller CD; Choi M; Forthuber B; Wang SJ; Rajagiriyil N; Salter BJ; Fuss M
    Radiat Oncol; 2007 Jul; 2():26. PubMed ID: 17629934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reirradiation for Recurrent Pediatric Central Nervous System Malignancies: A Multi-institutional Review.
    Rao AD; Rashid AS; Chen Q; Villar RC; Kobyzeva D; Nilsson K; Dieckmann K; Nechesnyuk A; Ermoian R; Alcorn S; MacDonald SM; Ladra MM; Ford EC; Winey BA; Figueiredo MLS; Chen MJ; Terezakis SA
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):634-641. PubMed ID: 29280457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study.
    Jeter MD; Gomez D; Nguyen QN; Komaki R; Zhang X; Zhu X; O'Reilly M; Fossella FV; Xu T; Wei X; Wang H; Yang W; Tsao A; Mohan R; Liao Z
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):730-737. PubMed ID: 29248169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large volume re-irradiation for recurrent meningioma with pulsed reduced dose rate radiotherapy.
    Witt JS; Musunuru HB; Bayliss RA; Howard SP
    J Neurooncol; 2019 Jan; 141(1):103-109. PubMed ID: 30392090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
    Li J; Lang J; Wang P; Kang S; Lin MH; Chen X; Chen F; Guo M; Chen L; Ma CM
    Med Dosim; 2014; 39(4):330-6. PubMed ID: 25087084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non-Small Cell Lung Cancer.
    Chao HH; Berman AT; Simone CB; Ciunci C; Gabriel P; Lin H; Both S; Langer C; Lelionis K; Rengan R; Hahn SM; Prabhu K; Fagundes M; Hartsell W; Mick R; Plastaras JP
    J Thorac Oncol; 2017 Feb; 12(2):281-292. PubMed ID: 27826034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after reirradiation of spinal metastasis with stereotactic body radiation therapy (SBRT): a retrospective single institutional study.
    Sasamura K; Suzuki R; Kozuka T; Yoshimura R; Yoshioka Y; Oguchi M
    J Radiat Res; 2020 Nov; 61(6):929-934. PubMed ID: 32766715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
    Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-Modulated Radiation Therapy With Dose Painting: A Brain-Sparing Technique for Intracranial Germ Cell Tumors.
    Yang JC; Terezakis SA; Dunkel IJ; Gilheeney SW; Wolden SL
    Pediatr Blood Cancer; 2016 Apr; 63(4):646-51. PubMed ID: 26703370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses.
    Takiar V; Garden AS; Ma D; Morrison WH; Edson M; Zafereo ME; Gunn GB; Fuller CD; Beadle B; Frank SJ; William WN; Kies M; El-Naggar AK; Weber R; Rosenthal DI; Phan J
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1117-31. PubMed ID: 27354127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver reirradiation for patients with hepatocellular carcinoma and liver metastasis.
    McDuff SGR; Remillard KA; Zheng H; Raldow AC; Wo JY; Eyler CE; Drapek LC; Goyal L; Blaszkowsky LS; Clark JW; Allen JN; Parikh AR; Ryan DP; Ferrone CR; Tanabe KK; Wolfgang JA; Zhu AX; Hong TS
    Pract Radiat Oncol; 2018; 8(6):414-421. PubMed ID: 29937235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: disease control, survival and toxicity.
    Duprez F; Berwouts D; Madani I; Bonte K; Boterberg T; De Gersem W; Deron P; Huvenne W; De Neve W
    Radiother Oncol; 2014 Jun; 111(3):388-92. PubMed ID: 24998706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.